Castle Biosciences Inc is a molecular diagnostics company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CSTL is expected to report earnings to fall 117.25% to -5 cents per share on May 12
Q1'25
Est.
$-0.06
Q4'24
Beat
by $0.31
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.58
Q1'24
Beat
by $0.23
The last earnings report on February 27 showed earnings per share of 31 cents, beating the estimate of 0 cents. With 454.03K shares outstanding, the current market capitalization sits at 608.02M.